TTLL12: A promising therapeutic target for prostate cancer

被引：0
|
作者：
Wasylyk, Bohdan [1 ]
Semenchenko, Kostyantin [1 ]
Wasylyk, Christine [1 ]
Brants, Jan [1 ]
Jung, Alain [2 ]
Abecassis, Joseph [2 ]
机构：
[1] IGBMC, Illkirch Graffenstaden, France
[2] Canc Paul Strauss, Strasbourg, France
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4015
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TTLL12 expression in ovarian cancer correlates with a poor outcome
    Yang, Shangjie
    Liang, Yanping
    Qian, Haihong
    Li, Qiuhong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (02): : 239 - 247
  • [2] Effect of TTLL12 on tubulin tyrosine nitration as a novel target for screening anticancer drugs in vitro
    Xue, Lingli
    Zeng, Yan
    Fang, Chuan
    Cheng, Wei
    Li, Yadong
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [3] Identification of a novel transcript isoform of the TTLL12 gene in human cancers
    Wen, Ruiling
    Xiao, Yingying
    Zhang, Yuhua
    Yang, Min
    Lin, Yongping
    Tang, Jun
    ONCOLOGY REPORTS, 2016, 36 (06) : 3172 - 3180
  • [4] TTLL12 is required for primary ciliary axoneme formation in polarized epithelial cells
    Ceglowski, Julia
    Hoffman, Huxley K.
    Neumann, Andrew J.
    Hoff, Katie J.
    McCurdy, Bailey L.
    Moore, Jeffrey K.
    Prekeris, Rytis
    EMBO REPORTS, 2024, 25 (01) : 198 - 227
  • [5] HMGB1: A Promising Therapeutic Target for Prostate Cancer
    Gnanasekar, Munirathinam
    Kalyanasundaram, Ramaswamy
    Zheng, Guoxing
    Chen, Aoshuang
    Bosland, Maarten C.
    Kajdacsy-Balla, Andre
    PROSTATE CANCER, 2013, 2013
  • [6] NF-κB signaling in prostate cancer: A promising therapeutic target?
    Garima Jain
    Marcus V. Cronauer
    Mark Schrader
    Peter Möller
    Ralf B. Marienfeld
    World Journal of Urology, 2012, 30 : 303 - 310
  • [7] NF-κB signaling in prostate cancer: A promising therapeutic target?
    Jain, Garima
    Cronauer, Marcus V.
    Schrader, Mark
    Moeller, Peter
    Marienfeld, Ralf B.
    WORLD JOURNAL OF UROLOGY, 2012, 30 (03) : 303 - 310
  • [8] MUC1 is a promising therapeutic target for prostate cancer therapy
    Li, Y.
    Cozzi, P. J.
    CURRENT CANCER DRUG TARGETS, 2007, 7 (03) : 259 - 271
  • [9] TTLL12 Inhibits the Activation of Cellular Antiviral Signaling through Interaction with VISA/MAVS
    Ju, Lin-Gao
    Zhu, Yuan
    Lei, Pin-Ji
    Yan, Dong
    Zhu, Kun
    Wang, Xiang
    Li, Qing-Lan
    Li, Xue-Jing
    Chen, Jian-Wen
    Li, Lian-Yun
    Wu, Min
    JOURNAL OF IMMUNOLOGY, 2017, 198 (03): : 1274 - 1284
  • [10] TUMOR-DERIVED TTLL12 RECRUITS MYELOID-DERIVED SUPPRESSOR CELLS TO PROMOTE TUMOR PROGRESSION OF COLORECTAL CANCER
    Chen, Dongwen
    Cai, Kuntai
    Hu, Peishan
    Wu, Xiao-Jian
    GASTROENTEROLOGY, 2024, 166 (05) : S1280 - S1281
12345